Milbank LLP Litigation special counsel Daniel J. Rosenthal led a lecture on antitrust considerations in international business transactions at George Washington University Law School on March 20, 2024. The lecture compared and contrasted the procedural and substantive issues that arise under merger control laws in the US, Europe and elsewhere as well as other relevant antitrust considerations in the context of a multi-jurisdictional transaction.
Mr. Rosenthal is widely considered a "go-to" practitioner for government merger and non-merger investigations, as well as for counseling on antitrust issues. He has a proven track record advising clients on complex cross-border transactions with multiple merger clearance requirements. He has broad experience handling complex antitrust issues in a variety of industries such as healthcare, pharmaceuticals, biotechnology, manufacturing, oil & gas, solid waste, transportation, automobile components, semiconductors, software, hardware, chemicals, publishing, renewable energy, entertainment, and retail sales.
Mr. Rosenthal has successfully defended non-merger investigations, including investigations of violations of Section 8 of the Clayton Act, and has advocated for government intervention on behalf of parties adversely impacted by proposed mergers. He also advises clients on issues relating to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), as well as international merger notification requirements. Clients turn to Mr. Rosenthal on a variety of antitrust risk management issues relating to business initiatives such as joint ventures, pricing and distribution strategies, information and data-sharing, and trade association and industry-wide collaborative efforts.
